Keyphrases
Androgen Deprivation Therapy
100%
Alzheimer's Disease
100%
Mouse Model
100%
Prostate Cancer
54%
Disease Onset
18%
Disease Progression
18%
Pten
18%
Prostate
18%
Alzheimer's Disease Model
18%
Clinically Significant
18%
Quality of Life
9%
Genetic Approach
9%
Inflammation
9%
Disease-related
9%
Neurodegenerative Diseases
9%
Tumor
9%
LoxP
9%
Epidemiologic Studies
9%
Therapy Treatment
9%
Complex Interactions
9%
Human Patients
9%
Androgen Depletion
9%
Knock-in Mouse Model
9%
Prostate Cancer Model
9%
Immune Response
9%
Clinical Treatment
9%
Genetic Engineering
9%
Common Cancers
9%
Cancer Population
9%
Mouse Genetics
9%
Age-related
9%
Disease Development
9%
Cancer Mortality
9%
Pathological Changes
9%
Public Health Risk
9%
Prostate Cancer Patients
9%
Negative Effects
9%
Cancer Causes
9%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Mouse Model
100%
Androgen
100%
Prostate Cancer
66%
Disease Model
16%
Mouse
8%
Inflammation
8%
Disease Course
8%
Neoplasm
8%
Epidemiology
8%
Amyloid
8%
Knockout Mouse
8%
Cancer Mortality
8%
Degenerative Disease
8%
Malignant Neoplasm
8%
Medicine and Dentistry
Alzheimer's Disease
100%
Androgen Deprivation Therapy
100%
Prostate Cancer
72%
Disease Model
18%
Population
9%
Neoplasm
9%
Androgen
9%
Cancer Mortality
9%
Degenerative Disease
9%
Amyloid
9%
Lifespan
9%
Cohort Effect
9%
Immune Response
9%
Quality of Life
9%
Malignant Neoplasm
9%
Disease Course
9%
Public Health
9%